Alithya Group Inc. (ALYAF) Financial Overview and Market Performance

• Alithya Group Inc. (PNK:ALYAF) reported earnings per share of $0.05, surpassing the estimated $0.03, indicating effective cost management and operational efficiency.
• The company experienced a revenue shortfall, generating approximately $87.1 million against the estimated $88.59 million, pointing to challenges in sales growth.
• Alithya's price-to-sales ratio of 0.45 suggests the stock is undervalued relative to its sales per share.

Alithya Group Inc., trading under the symbol ALYAF on the OTC exchange, is a prominent player in the digital strategy and technology services sector. The company boasts a diverse operational footprint across financial services, healthcare, and manufacturing sectors. Despite facing stiff competition from other technology consulting firms, Alithya has demonstrated resilience and strategic acumen in its financial and operational performance.

On June 12, 2025, Alithya made headlines by reporting an earnings per share of $0.05, significantly outperforming the consensus estimate of $0.03. This positive earnings surprise is a testament to the company's effective cost management and operational efficiency. However, Alithya encountered hurdles on the revenue front, with figures reaching approximately $87.1 million, which fell short of the anticipated $88.59 million. This discrepancy underscores the challenges Alithya faces in achieving its expected sales growth.

In its Q4 2025 earnings conference call, Alithya unveiled a 4% year-over-year increase in revenues, which amounted to C$125.3 million (approximately $87.1 million) compared to $120.5 million in the corresponding quarter of the previous year. This growth is indicative of the company's ability to expand its business segments and adapt to market demands, further evidenced by a sequential revenue increase of $9.5 million, or 8.3%, from the third quarter.

The price-to-sales ratio of 0.45, suggesting that the stock is undervalued relative to its sales per share. Additionally, the enterprise value to sales ratio stands at approximately 0.70, indicating a slightly higher valuation when considering debt levels. Alithya's financial health, as evidenced by its debt-to-equity ratio of 0.75 and a current ratio of 1.28, suggests a moderate level of debt relative to equity and a reasonable level of liquidity to cover short-term liabilities. These figures provide a glimpse into the company's financial stability, despite its current unprofitability.